TX-MARY-KAY
Mary Kay Inc., a corporate leader in global sustainability, is strengthening its roots in Lewisville. On May 10, the company partnered with the Arbor Day Foundation and Keep Lewisville Beautiful to host a tree planting event at Railroad Park to celebrate Mother Nature and Mother’s Day.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240514127551/en/
Trees planted at Railroad Park directly impact Lewisville communities by providing important ecosystem benefits in the Trinity River watershed. (Photo: Mary Kay Inc.)
“Through partnerships with organizations like the Arbor Day Foundation, Mary Kay is making positive environmental impact in ecosystems where we operate around the world,” said Ryan Rogers, CEO of Mary Kay, Inc., and grandson of Mary Kay Ash. “But change starts in your own backyard. We enjoyed ‘sprucing’ up the community by planting trees that will benefit local families for generations to come.”
Mary Kay volunteers planted 60 native trees along the trails and waterways in Railroad Park, symbolizing the company’s 60th anniversary of enriching the lives of women and their families worldwide and protecting the planet. The park is four miles from Mary Kay’s state-of-the-art Richard R. Rogers (R3) Manufacturing/R&D Center. Trees planted at this location directly impact Lewisville communities by providing much-needed shade in community spaces, enhancing the beautification of recreational areas, and providing important ecosystem benefits in the Trinity River watershed.
"We are thrilled to see Mary Kay contribute to the tree canopy of Lewisville,” said TJ Gilmore, Mayor of Lewisville. “This initiative is not only a breath of fresh air for our city but a testament to the flourishing partnership between our community and a corporation that continuously gives back. Together, we’re making Lewisville a better place to live and work."
Mary Kay’s partnership with the Arbor Day Foundation stretches back more than 16 years—and in that time, the company has helped plant 1.4 million trees around the world. Arbor Day Foundation is the world’s largest membership nonprofit dedicated to planting trees.
“The Arbor Day Foundation is dedicated to helping our local planting partners unlock the transformative power of trees in their community,” said Dan Lambe, Chief Executive of the Arbor Day Foundation. “Trees clean our air, cool our cities, and improve the lives of the people around them. We’re happy to partner again with Mary Kay and Keep Lewisville Beautiful to maximize the impact of the urban canopy and inspire more people to engage with nature in a meaningful way.”
Keep Lewisville Beautiful is a local environmental nonprofit that partners with organizations to plant trees and provide residents opportunities to care for Lewisville’s tree canopy on public lands.
“Tree planting is an investment in our community’s future,” said Amy Wells, Executive Director of Keep Lewisville Beautiful. “These trees will help create shade for families visiting Railroad Park, provide habitat to local wildlife, and will provide a multitude of ecological benefits for our local environment. Keep Lewisville Beautiful is excited to partner with Mary Kay and the Arbor Day Foundation to increase Lewisville’s tree canopy and make a visible difference in our community with Mary Kay volunteers. Their donation to our community and KLB will go a long way towards keeping Lewisville beautiful.”
Following the planting, the Lewisville Parks Department is committed to long-term maintenance and upkeep of the trees with supplemental watering, pruning, and care.
Did you know:
- R3 Manufacturing/R&D Center in Lewisville is named in honor of Mary Kay Inc.’s cofounder and Mary Kay Ash’s son, Richard R. Rogers.
- Built on 26 acres of land, R3 features state-of-the-art R&D laboratories and cutting-edge manufacturing technology.
- 57% of products manufactured at R3 are exported to Mary Kay’s international markets.
- R3 production capacity is up to 1.1 million products per day. The facility boasts 20 product-packaging lines and 21 processing vessels and mixing tanks.
- R3 is LEED Building Design and Construction Silver-Certified facility.
About Mary Kay
Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 35 countries. For 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
About the Arbor Day Foundation
Founded in 1972, the Arbor Day Foundation is the largest nonprofit membership organization dedicated to planting trees. Together with our partners, we have helped plant more than 500 million trees in neighborhoods, communities, cities, and forests throughout the world. Our vision is to lead toward a world where trees are used to solve issues critical to survival. Through our members, partners and programs, the Arbor Day Foundation inspires people across the globe to plant, nurture and celebrate trees. More information is available at arborday.org.
About Keep Lewisville Beautiful
Keep Lewisville Beautiful (KLB) is a non-profit and award-winning affiliate of Keep America Beautiful and Keep Texas Beautiful. KLB’s mission is to “engage the citizens of Lewisville through service and education to enhance their community environment”. Our vision is to partner with the community to promote environmental quality, making Lewisville the best place to live, work, and play. Annually, KLB volunteers contribute over 10,000 volunteer hours towards litter abatement, environmental education, and beautification programs, and remove 25+ TONS of trash from community green spaces and waterways. Learn more at keeplewisvillebeautiful.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514127551/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom